Bioanalysis in Latin America: where are we and where are we going?

“Regulatory agencies in Latin America are trying to amend their guidelines to the international standard. In the near future, most of the countries will adopt specific requirements for generic medicines and this fact will allow the bioanalysis community in this region to expand.” Bioanalysis (BA) has experienced very fast growth in Latin America (LATAM). The first BA guidelines were implemented in the region in 1998, starting in Mexico and Brazil. More than 12 years later, Brazil is leading the BA market, both in number of assays and regarding the technology used. Market size as well as governmental policies for generic...

To view this content, please register now for access

It's completely free